We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Comprehensive Gene Map of the Human Brain Developed

By LabMedica International staff writers
Posted on 26 Apr 2011
A new human brain atlas reveals more than 90% similarity among humans, and details genes at work throughout the brain to further scientific research and medical outcomes.

The Allen Institute for Brain Science (Seattle, WA, USA) has released the world's first anatomically and genomically comprehensive human brain map, a previously improbable endeavor made possible through leading-edge technology and more than four years of demanding studies and documentation. The mappings are the foundation for the Allen Human Brain Atlas, an online public resource developed to advance the Institute's goal to accelerate understanding of how the human brain works and fuel new discovery among the global research community.

In developing the Allen Human Brain Atlas, the Allen Institute has now characterized and mapped the biochemistry of two normal adult human brains, providing opportunities for scientists to study the brain with new detail and accuracy. The data reveal a remarkable 94% similarity between human brains, establishing strong patterns as a critical foundation for translational and clinical research. Moreover, data analysis from the two human brains indicate that at least 82% of all human genes are expressed in the brain, highlighting its great complexity while also providing an essential genetic blueprint to understand brain functionality better and fuel research in neurologic disease and other brain disorders.

"Until now, a definitive map of the human brain, at this level of detail, simply hasn't existed,” said Allan Jones, PhD, chief executive officer of the Allen Institute for Brain Science. "The Allen Human Brain Atlas provides never-before-seen views into our most complex and most important organ. Understanding how our genes are used in our brains will help scientists and the medical community better understand and discover new treatments for the full spectrum of brain diseases and disorders, from mental illness and drug addiction, to Alzheimer's and Parkinson's diseases, multiple sclerosis, autism, and more.”

Similar to a high-powered, multifunctional GPS (global positioning system) navigation system, the Allen Human Brain Atlas identifies 1,000 anatomic sites in the human brain, underscored by more than 100 million data points that indicate the particular gene expression and underlying biochemistry of each site. Scientists can utilize the Allen Human Brain Atlas to explore the human brain and identify how disease and trauma, including physical brain injuries and mental health disorders, affect specific areas of the brain. This resource makes it possible to pinpoint where a particular drug acts anatomically in the brain, to ultimately better control the successful outcome of numerous therapies.

"The Allen Institute is a powerful force in modern science,” said Dr. Edward Jones, neuroscientist at the University of California, Davis. "They've applied an industrialized approach and high-output technology to accomplish what no other lab has ever done. The original data produced for the mouse brain revolutionized neuroscience and now the Allen Human Brain Atlas delivers extremely rare and essential information that most researchers could not otherwise access. They are truly paving the way for the future of research."

The Allen Human Brain Atlas is free and available to scientists, physicians, and the education community as an online public resource (please see Related Links below).

Previously, as its inaugural initiative, the Allen Institute for Brain Science completed mappings of the adult mouse brain in 2006, similarly making the data available free to scientists. Overall, those data have led to a number of significant research advances worldwide, including the publishing of over 500 peer-reviewed papers citing the Allen Mouse Brain Atlas to support research conclusions.

A significant feature of the Atlas that makes it a powerful research tool is that it fully integrates several different kinds of data across different scales of brain exploration. Data incorporated into the Atlas include magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), as well as histology and gene expression data derived from both microarray and in-situ hybridization (ISH) approaches.

Users of the Allen Human Brain Atlas comprise a diverse range of biomedical researchers--primarily neuroscientists--throughout the world. They include scientists who study the human brain itself, as well as those working in mouse and other model systems, providing a rare and important opportunity for them to probe the relevance of the findings to humans. Some 4,000 unique visitors are now accessing the new Atlas each month.

It is anticipated that the Allen Human Brain Atlas will be used in small and large-scale applications to examine diseases and disorders, such as obesity, Parkinson's disease, autism, schizophrenia, Alzheimer's disease, and multiple sclerosis--as well as those exploring how the healthy brain works.

The Allen Institute for Brain Science will continue to expand the Allen Human Brain Atlas in the coming years, with new data from additional brains, as well as enhanced tools for searching, analyzing, and viewing the data.

The Allen Institute for Brain Science is a medical research organization focused on accelerating understanding of the human brain by driving discovery for the broader scientific community.

Related Links:

Allen Institute for Brain Science
Allen Human Brain Atlas



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Pipette Calibration System
Artel PCS®

Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Experts used an OpenAI reasoning model to reanalyze 376 previously unsolved cases and surface leads for 18 diagnoses (Image credit: iStock)

AI Reasoning Model Generates Diagnostic Leads for Unresolved Rare Disease Cases

Rare genetic diseases often leave families without definitive answers, even after genome sequencing and expert review. As scientific evidence evolves and clinical data remain fragmented across systems,... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
ADLM